VITASPRING BIOMEDICAL CO., LTD. Cash and Restricted Cash
VITASPRING BIOMEDICAL CO., LTD. (VSBC) had Cash and Restricted Cash of $13.37 thousand as of 2026-07-31, per its 10-Q filed 2026-09-17.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-17
- 2026-07-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $13.37K.
- 2026-04-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.17K.
- 2026-01-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.08K.
- 2025-10-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.96K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-07-31 | $13.37K 10-Q · filed 2026-09-17 |
| 2026-04-30 | $8.17K 10-Q · filed 2026-06-17 |
| 2026-01-31 | $2.08K 10-Q · filed 2026-09-17 |
| 2025-10-31 | $1.96K 10-Q · filed 2026-06-17 |
| 2025-07-31 | $799.00 10-Q · filed 2026-09-17 |
| 2025-04-30 | $0.00 10-Q · filed 2026-06-17 |
| 2025-01-31 | $272.00 10-Q · filed 2026-09-17 |
| 2024-10-31 | $2.06K 10-Q · filed 2026-06-17 |
| 2024-07-31 | $5.53K 10-Q · filed 2026-06-17 |
| 2024-04-30 | $968.00 10-Q · filed 2026-06-15 |
| 2024-01-31 | $13.00 10-Q · filed 2026-06-17 |
| 2023-10-31 | $2.64K 10-Q · filed 2026-05-06 |
| 2023-07-31 | $7.18K 10-Q · filed 2026-04-22 |
| 2023-04-30 | $2.99K 10-Q · filed 2026-04-02 |
| 2023-01-31 | $29.66K 10-K · filed 2026-06-08 |
| 2022-10-31 | $24.05K 10-Q · filed 2026-01-30 |
| 2022-07-31 | $21.59K 10-Q · filed 2026-01-23 |
| 2022-04-30 | $79.15K 10-Q · filed 2026-01-13 |
| 2022-01-31 | $107.21K 10-K · filed 2026-03-12 |
| 2021-01-31 | $45.40K 10-K · filed 2025-12-01 |